INVESTIGADORES
PEREZ LLORET Santiago
artículos
MATTA, M.; PAVY-LE TRAON, A.; PEREZ-LLORET, S.; LAPORTE, C.; BERDUGO, I.; NASR, N.; HANAIRE, H.; SENARD, J. M.
Predictors of Cardiovascular Autonomic Neuropathy Onset and Progression in a Cohort of Type 1 Diabetic Patients
Journal of Diabetes Research; Año: 2018 vol. 2018 p. 1 - 8
PEREZ-LLORET, SANTIAGO; RASCOL, OLIVIER
Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia
JOURNAL OF NEURAL TRANSMISSION. GENERAL SECTION.; Año: 2018
REY, MARÍA VERÓNICA; MOLINA, LUIS; RECINOS, BYRON; PAZ, BEZNER; ROVELO, MAURICIO; RODRIGUEZ ELIAS, FANNY ELIZABETH; CALDERÓN, JOSÉ; ARELLANO, ARTURO; PEREZ-LLORET, SANTIAGO
Movement Disorders after Exposure to Antipsychotic Drugs in Patients with Depressive Disorders
CLINICAL NEUROPHARMACOLOGY; Año: 2018 vol. 41 p. 177 - 180
PEREZ-LLORET, S.; NEGRE-PAGES, L.; DAMIER, P.; DELVAL, A.; DERKINDEREN, P.; DESTÉE, A.; MEISSNER, W. G.; TISON, F.; RASCOL, O.
L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey
EUROPEAN JOURNAL OF NEUROLOGY; Año: 2017 vol. 24 p. 1532 - 1538
PEREZ-LLORET, SANTIAGO; OTERO-LOSADA, MATILDE; TOBLLI, JORGE E.; CAPANI, FRANCISCO
Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease
EXPERT OPINION ON INVESTIGATIONAL DRUGS; Año: 2017 vol. 26 p. 1163 - 1173
SANTIAGO PÉREZ LLORET; OLIVIER RASCOL
The safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease.
Expert Review of Neurotherpautics; Lugar: Londres; Año: 2016 vol. 16 p. 245 - 258
SANTIAGO PÉREZ LLORET; OLIVIER RASCOL
Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.
CNS DRUGS; Año: 2016 vol. 30 p. 703 - 717
JAMES CRISPO; ALICE WILLIS; DP THIBAULT; YANNICK FORTIN; HAYS HD; MCNAIR MC; BJERRE LM; KOHEN DE; SANTIAGO PÉREZ LLORET; DAVID MATTISON; DANIEL KREWSKI
Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease.
PLOS ONE; Lugar: San Francisco; Año: 2016 vol. 11 p. 21 - 28
CURY RG; GALHARDONI R; FONOFF ET; SANTAIGO PEREZ-LLORET; DOS SANTOS MG; BARBOSA ER; TEXEIRA MG; CIAMPI DE ANDRADE
Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms.
EUROPEAN JOURNAL OF PAIN; Lugar: Amsterdam; Año: 2016 vol. 20 p. 151 - 165
PATRICIO MILLAR VERNETTI; MALCO ROSSI; DANIEL CERQUETTI; SANTIAGO PÉREZ LLORET; MARCELO MERELLO
Comparison of Olfactory Identification Patterns among Parkinson's Disease Patients from Different Countries.
CHEMICAL SENSES; Lugar: Oxford; Año: 2016 vol. 41 p. 77 - 83
SANTIAGO PÉREZ LLORET
Investigational drugs for autonomic dysfunction in Parkinson's disease.
EXPERT OPINION ON INVESTIGATIONAL DRUGS; Lugar: London; Año: 2016 vol. 25 p. 259 - 262
MOLINA L; RECINOS B; ROVELO M; ELIAS RODRIGUEZ; CALDERON J; ARELLANO A; POMATA S; MARIA VERÓNICA REY; SANTIAGO PÉREZ LLORET
Factors Related to Early Clinical Effects of Quetiapine Extended-Release: A Multinational, Prospective, Observational Study.
CLINICAL DRUG INVESTIGATION; Lugar: Sydney; Año: 2016 vol. 36 p. 491 - 497
PEREZ-LLORET, SANTIAGO; PERALTA, MARÍA CECILIA; BARRANTES, FRANCISCO J.
Pharmacotherapies for Parkinson’s disease symptoms related to cholinergic degeneration
EXPERT OPINION ON PHARMACOTHERAPY; Año: 2016 vol. 17 p. 2405 - 2415
NEAL FARBER; SANTIAGO PÉREZ LLORET; ELKAN GAMZU
Design and development of a novel supportive care product for the treatment of sialorrhea in Parkinson's disease
Current Topics in Medicinal Chemistry; Lugar: Oak Park; Año: 2015 vol. 15 p. 939 - 954
MALCO ROSSI; MARCELO MERELLO; SANTIAGO PEREZ LLORET
Management of constipation in Parkinson's disease
EXPERT OPINION ON PHARMACOTHERAPY; Lugar: London; Año: 2015 vol. 16 p. 547 - 557
OLIVIER RASCOL; SANTIAGO PÉREZ LLORET; JOAQUIM FERREIRA
New treatments for levodopa-induced motor complications.
MOVEMENT DISORDERS; Lugar: New York; Año: 2015 vol. 30 p. 1451 - 1460
LUCA RATTI; LAURENCE NEGRE-PAGES; SANTIAGO PÉREZ LLORET; MANNI R; PHILIPPE DAMIER; FRANCOIS TISON; ALAIN DESTEE; OLIVIER RASCOL
Subjective sleep dysfunction and insomnia symptoms in Parkinson's disease: Insights from a cross-sectional evaluation of the French CoPark cohort.
PARKINSONISM & RELATED DISORDERS; Lugar: Amsterdam; Año: 2015 vol. 21 p. 1323 - 1329
MALCO ROSSI; SANTIAGO PÉREZ LLORET; PATRICIO MILLAR VERNETTI; LUCAS DRUCAROFF; E CONSTANZO; DIEGO BALLESTEROS; ANDREA BRIL; DANIEL CERQUETTI; SALVADOR GUINJOAN; MARCELO MERELLO
Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease.
MOVEMENT DISORDERS; Lugar: New York; Año: 2015
JAMES CRISPO; YANNICK FORTIN; DP THIBAULT; M EMONS; LM BJERRE; DE KOHEN; SANTIAGO PEREZ LLORET; DAVID MATTISON; ALICE WILLIS; DANIEL KREWSKI
Trends in inpatient antiparkinson drug use in the USA, 2001-2012
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY; Lugar: Berlin; Año: 2015
A. PAVY-LE TRAON; A PIEDVACHE; SANTIAGO PÉREZ LLORET; CALANDRA-BUONARA; VALERIE COCHEN; CARLO COLOSIMO; P CORTELLI; RACHEL DEBS; DUERR S; A FIANCULLI; ALEXANDRA FOUBERT-SAMIER; ANGELA GARDELAT; T GUREVICH; F KRISMER; WERNER POEWE; FRANCOIS TISON; C TRANCHANT; GREGOR WENNING; WASSILIOS MEISSNER; OLIVIER RASCOL
New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study
JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY; Lugar: Londres; Año: 2015
OLIVIER RASCOL; SANTIAGO P¨¦REZ LLORET; PHILIPPE DAMIER; ANTOINE DELVAL; PAUL DERKINDEREN; ALAIN DESTEE; WASSILIOS MEISSNER; FRANCOIS TISON; LAURENCE NEGRE-PAGES
Falls in ambulatory non-demented patients with Parkinson's disease
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT; Lugar: Berlin; Año: 2015
SANTIAGO PÉREZ LLORET; MARIA VERÓNICA REY; JAMES CRISPO; DANIEL KREWSKI; MARISE LAPEYRE-MESTRE; JEAN-LOUIS MONTASTRUC; OLIVIER RASCOL
Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients
EXPERT OPINION ON DRUG SAFETY; Lugar: London; Año: 2014 vol. 13 p. 351 - 360
MALCO ROSSI; SANTIAGO PÉREZ LLORET; LILIANA DOLDAN; DANIEL CERQUETTI; JORGE BALEJ; PATRICIO MILLAR VERNETTI; MARTIN HAWKES; ANGEL CAMMAROTA; MARCELO MERELLO
Autosomal dominant cerebellar ataxias: a systematic review of clinical features
EUROPEAN JOURNAL OF NEUROLOGY; Lugar: Londres; Año: 2014 vol. 21 p. 607 - 615
SANTIAGO PÉREZ LLORET; JOAQUIN DIEZ; MN DOMÉ; AA DELVENNE; NESTOR BRAIDOT; DANIEL CARDINALI; DANIEL VIGO
Effects of different "relaxing" music styles on the autonomic nervous system
NOISE AND HEALTH; Lugar: London; Año: 2014 vol. 16 p. 279 - 284
SANTIAGO PÉREZ LLORET; LAURENCE NEGRE-PAGES; PHILIPPE DAMIER; ANTOINE DELVAL; PAUL DERKINDEREN; ALAIN DESTEE; WASSILIOS MEISSNER; LUDGIW SCHELOWSKY; FRANCOIS TISON; OLIVIER RASCOL
Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease
JAMA Neurology; Lugar: New York; Año: 2014 vol. 71 p. 884 - 890
MALCO ROSSI; SANTIAGO PÉREZ LLORET; LUCIA DOLDAN; DANIEL CERQUETTI; JORGE BALEJ; PATRICIO MILLAR VERNETTI; H HAWKES; ANGEL CAMMAROTA; MARCELO MERELLO
Autosomal dominant cerebellar ataxias: a systematic review of clinical features
EUROPEAN JOURNAL OF NEUROLOGY; Lugar: Londres; Año: 2014 vol. 21 p. 607 - 615
MARIA VERÓNICA REY; SANTIAGO PÉREZ LLORET; ANNE PAVY; WASSILIOS MEISSNER; FRANCOIS TISON; OLIVIER RASCOL
A cross-sectional study on drug use in multiple system atrophy
CNS DRUGS; Lugar: Sydney; Año: 2014 vol. 28 p. 483 - 490
SANTIAGO PEREZ LLORET; MARCELO MERELLO
Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline vs tozadenant
EXPERT OPINION ON PHARMACOTHERAPY; Lugar: London; Año: 2014
MARIA VERÓNICA REY; SANTIAGO PEREZ LLORET; ANNE PAVY; WASSILIOS MEISSNER; FRANCOIS TISON; OLIVIER RASCOL
A cross-sectional study on Drug Utilization in Multiple System Atrophy
CNS DRUGS; Año: 2014
SANTIAGO PEREZ LLORET; MARIA VERÓNICA REY; ANNE PAVY; OLIVIER RASCOL
Emerging drugs for autonomic dysfunction in Parkinson's disease
EXPERT OPINION ON EMERGING DRUGS; Lugar: London; Año: 2013 vol. 18 p. 39 - 53
SANTIAGO PÉREZ LLORET; ALEJANDRO J. VIDELA; ALBA RICHADEAU; DANIEL E. VIGO; MALCO ROSSI; DANIEL P. CARDINALI; DANIEL PEREZ-CHADA
A multi-step pathway connecting short sleep duration to daytime somnolence, reduced attention, and poor academic performance: an exploratory cross-sectional study in teenagers.
JOURNAL OF CLINICAL SLEEP MEDICINE; Lugar: Nueva York; Año: 2013 vol. 9 p. 469 - 473
SANTIAGO PEREZ LLORET
Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease: an old drug revisited
EUROPEAN JOURNAL OF NEUROLOGY; Lugar: Londres; Año: 2013 vol. 20 p. 1427 - 1428
SANTIAGO PÉREZ LLORET; MARIA VERÓNICA REY; ANNE PAVY; OLIVIER RASCOL
Droxidopa for the treatment of neurogenic orthostatic hypotension and other symptoms of neurodegenerative disorders
Expert Opinion in Orphan Drugs; Año: 2013
SOLERNO JI; DANIEL PEREZ-CHADA; GUINJOAN SR; SANTIAGO PÉREZ LLORET; HEDDERWICK A; VIDAL MF; DANIEL CARDINALI; DANIEL E. VIGO
Cardiac autonomic activity predicts dominance in verbal over spatial reasoning tasks: results from a preliminary study.
AUTONOMIC NEUROSCIENCE.; Lugar: Amsterdam; Año: 2012 vol. 167 p. 78 - 80
SANTIAGO PÉREZ LLORET; ROJAS GM; MENONI MC; RUIZ G; VELÁSQUEZ C; RODRIGUEZ H, ; MARIA VERÓNICA REY; DANIEL CARDINALI
Pregabalin beneficial effects on sleep quality or health-related quality of life are poorly correlated with reduction on pain intensity after an 8-week treatment course.
CLINICAL NEUROPHARMACOLOGY; Lugar: Philadelphia; Año: 2012 vol. 35 p. 21 - 24
SANTIAGO P¨¦REZ LLORET; MARIA VER¨®NICA REY; FABRE N; FABIENNE ORY-MAGNE; UMBERTO SPAMPINATO; JEAN-LOUIS MONTASTRUC; OLIVIER RASCOL
Do Parkinson's disease patients disclose their adverse events spontaneously?
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY; Lugar: Berlin; Año: 2012 vol. 68 p. 857 - 865
MILLAR VERNETTI P; SANTIAGO PÉREZ LLORET; ROSSI M; CERQUETTI D; MARCELO MERELLO
Validation of a new scale to assess olfactory dysfunction in patients with Parkinson's disease.
PARKINSONISM & RELATED DISORDERS; Lugar: Amsterdam; Año: 2012 vol. 18 p. 358 - 361
SANTIAGO PÉREZ LLORET; MARIA VERÓNICA REY; LUCA RATTI; OLIVIER RASCOL
Rotigotine transdermal patch for the treatment of Parkinson's Disease.
FUNDAM. CLIN. PHARMACOL.; Lugar: Londres; Año: 2012 p. 1 - 28
SANTIAGO P¨¦REZ LLORET; MARIA VER¨®NICA REY; NELLY FABRE; FABIENNE ORY-MAGNE; UMBERTO SPAMPINATO; SENARD JM; PAVY A; JEAN-LOUIS MONTASTRUC; OLIVIER RASCOL
Factors related to orthostatic hypotension in Parkinson's disease.
PARKINSONISM & RELATED DISORDERS; Lugar: Amsterdam; Año: 2012 vol. 18 p. 501 - 505
SANTIAGO PEREZ LLORET; MARIA VERÓNICA REY; DELLAPINA E; PELLAPRAT J; BREFEL-COURBON C; RASCOL O
Emerging analgesic drugs for Parkinson's disease.
EXPERT OPINION ON EMERGING DRUGS; Lugar: London; Año: 2012 vol. 17 p. 157 - 171
SANTIAGO PÉREZ LLORET; OLIVIER RASCOL
Parkinson disease: Serotonin reuptake inhibitors for depression in PD.
NATURE REVIEWS NEUROLOGY; Lugar: Londres; Año: 2012 vol. 8 p. 365 - 366
SANTIAGO PÉREZ LLORET; OLMOS L; DE MENA F; PIECZANSKI P; RODRIGUEZ MONCALVO JJ
Bioequivalence of Lamotrigine 50-mg Tablets in Healthy Male Volunteers: a Randomized, Single-Dose, 2-Period, 2-Sequence Crossover Study.
ARZNEIMITTEL FORSCHUNG DRUG RESEARCH; Año: 2012 p. 1 - 11
SANTIAGO PEREZ LLORET; MARIA VERÓNICA REY; NELLY FABRE; FABIENNE ORY-MAGNE; UMBERTO SPAMPINATO; CHRISTINE BREFEL-COURBON; JEAN-LOUIS MONTASTRUC; OLIVIER RASCOL
Prevalence and Pharmacological Factors Associated With Impulse-Control Disorder Symptoms in Patients With Parkinson Disease
CLINICAL NEUROPHARMACOLOGY; Lugar: Philadelphia; Año: 2012 vol. 35 p. 261 - 265
SANTIAGO PEREZ LLORET; MARIA VERÓNICA REY; EMMANUELLE BONDON-GUITTON; OLIVIER RASCOL; JEAN-LOUIS MONTASTRUC
Drugs Associated With Restless Legs Syndrome: A Case/Noncase Study in the French Pharmacovigilance Database
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY; Lugar: Philadelphia; Año: 2012 vol. 32 p. 824 - 827
SANTIAGO PEREZ-LLORET; OLIVIER RASCOL
Safety of rasagiline for the treatment of Parkinson's disease.
EXPERT OPINION ON DRUG SAFETY; Año: 2011 p. 1 - 11
SANTIAGO PEREZ-LLORET; LAURENCE NEGRE-PAGES; ANA OJERO; PHILIPPE DAMIER; ALAIN DESTEE; MARCELO MERELLO; OLIVIER RASCOL
Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminary analysis from the French COPARK cohort.
EUROPEAN JOURNAL OF NEUROLOGY; Año: 2011 p. 1 - 10
SANTIAGO PEREZ-LLORET; MALCO ROSSI; MARCELO MERELLO; DANIEL CARDINALI
Non-motor symptoms groups in Parkinson’s Disease patients. Results of a pilot, exploratory study.
Parkinson's Disease; Año: 2011
OLIVIER RASCOL; JOAQUIM FERREIRA; LAURENCE NEGRE-PAGES; SANTIAGO PEREZ-LLORET; LUCETTE LACOMBLEZ; MONIQUE GALITZKY; JC LEMARIÉ; JC CORVOL; JONATHAN BROTCHIE; LAURA BOSSI
A proof-of-concept randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson’s disease.
FUNDAM. CLIN. PHARMACOL.; Año: 2011 p. 1 - 15
SANTIAGO PÉREZ LLORET; GABRIELA NANO; ANDREA CARROSELLA; ELKAN GAMZU; MARCELO MERELLO
A double-blind, placebo-controlled, randomized, crossover pilot study of the safety and efficacy of multiple doses of intra-oral tropicamide films for the short-term relief of sialorrhea symptoms in Parkinson's disease patients.
JOURNAL OF THE NEUROLOGICAL SCIENCES; Lugar: Amsterdam; Año: 2011 vol. 15 p. 248 - 250
EMMANUELLE BONDON-GUITTON; SANTIAGO PÉREZ LLORET; HALEH BAGHERI; CHRISTINE BREFEL; OLIVIER RASCOL; JEAN-LOUIS MONTASTRUC
Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France.
MOVEMENT DISORDERS; Lugar: New York; Año: 2011 vol. 26 p. 2226 - 2231
DIEZ JJ; DANIEL E. VIGO; SANTIAGO PÉREZ LLORET; RIGTERS S; ROLE N; CARDINALI DP; DANIEL PEREZ-CHADA
Sleep habits, alertness, cortisol levels, and cardiac autonomic activity in short-distance bus drivers: differences between morning and afternoon shifts.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE / AMERICAN COLLEGE OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE.; Lugar: Philadelphia; Año: 2011 vol. 53 p. 806 - 811
SANTIAGO PÉREZ LLORET; MARIA VERÓNICA REY; LUCA RATTI; OLIVIER RASCOL
Pramipexole for the treatment of early Parkinson's disease.
Expert review of neurotherapeutics; Lugar: Londres; Año: 2011 vol. 11 p. 925 - 935
SEPPI K; WEINTRAUB D; COEHLO M; SANTIAGO PéREZ LLORET; FOX SH; KATZENSCHLAGER R; HAMETNER EM; POEWE W; OLIVIER RASCOL; GOETZ CG; SAMPAIO C
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.
MOVEMENT DISORDERS; Lugar: New York; Año: 2011 vol. 26 p. 42 - 80
SANTIAGO PEREZ-LLORET; JORGE TOBLLI; DANIEL CARDINALI; JOSÉ MILEI
Gender differences in age-related increase of asleep blood pressure.
ARCHIVES OF GERONTOLOGY AND GERIATRICS; Año: 2010 vol. 50 p. 319 - 322
MALCO ROSSI; ELIANA ROLDÁN GERSCOVICH; DELFINA DE ACHAVAL; SANTIAGO PEREZ-LLORET; DANIEL CERQUETTI; ANGEL CAMMAROTA; MARÍA INÉS NOUZEILLES; RAUL FAHRER; MARCELO MERELLO; RAMÓN LEIGUARDA
Decision-making in Parkinson's disease patients with and without pathological gambling.
EUROPEAN JOURNAL OF NEUROLOGY; Año: 2010 vol. 17 p. 97 - 102
SANTIAGO PEREZ-LLORET; MALCO ROSSI; DANIEL P. CARDINALI; MARCELO MERELLO
Activity-rest rhythm abnormalities in Parkinson's disease patients are related to dopaminergic therapy.
THE INTERNATIONAL JOURNAL OF NEUROSCIENCE.; Año: 2010 vol. 120 p. 11 - 16
SANTIAGO PEREZ-LLORET; MALCO ROSSI; DANIEL P. CARDINALI; MARCELO MERELLO
Actigraphic evaluation of motor fluctuations in patients with Parkinson's disease.
THE INTERNATIONAL JOURNAL OF NEUROSCIENCE.; Año: 2010 vol. 120 p. 137 - 143
SANTIAGO PEREZ-LLORET; EMMANUELLE BONDON-GUITTON; OLIVIER RASCOL; JEAN-LOUIS MONTASTRUC
Adverse drug reactions to dopamine agonists: a comparative study in the French Pharmacovigilance Database.
MOVEMENT DISORDERS; Año: 2010 vol. 25 p. 1876 - 1880
SANTIAGO PEREZ-LLORET; OLIVIER RASCOL
Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease.
EXPERT OPINION ON PHARMACOTHERAPY; Año: 2010 vol. 11 p. 2221 - 2230
DANIEL E. VIGO; SANTIAGO PEREZ LLORET; ALEJANDRO J. VIDELA; DANIEL PEREZ-CHADA; HORACIO M. HÜNICKEN; JORGE MERCURI; RAMÓN ROMERO; LEONARDO C. NICOLA SIRI; DANIEL CARDINALI
Heart rate nonlinear dynamics during sudden hypoxia at 8230 m simulated altitude.
Wilderness Environ Med; Año: 2010 vol. 21 p. 4 - 10
EXECUTIVE STUDY GROUP; SANTIAGO PEREZ-LLORET
Parkinson's disease dementia can be easily detected in routine clinical practice.
MOVEMENT DISORDERS; Año: 2010 vol. 25 p. 2769 - 2776
SANTIAGO PEREZ-LLORET
Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease.
CNS DRUGS; Año: 2010 vol. 24 p. 941 - 968
MARCO AURELIO REYES; SANTIAGO PEREZ-LLORET; ELIANA ROLDÁN GERSCOVICH; MARIA EUGENIA MARTIN; RAMÓN LEIGUARDA; MARCELO MERELLO
Addenbrooke's Cognitive Examination validation in Parkinson's disease.
EUROPEAN JOURNAL OF NEUROLOGY; Año: 2009 vol. 16 p. 142 - 147
OLIVIER RASCOL; SANTIAGO PEREZ-LLORET
Rotigotine transdermal delivery for the treatment of Parkinson’s disease.
EXPERT OPINION ON PHARMACOTHERAPY; Año: 2009 vol. 10 p. 677 - 691
SANTIAGO PEREZ-LLORET; MALCO ROSSI; DANIEL CARDINALI; MARCELO MERELLO
Parkinson's disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients.
JOURNAL OF NEUROLOGY; Año: 2009 vol. 256 p. 1480 - 1484
MARCELO MERELLO; SOL CAVANAGH; SANTIAGO PEREZ-LLORET; ELIANA ROLDÁN GERSCOVICH; VERÓNICA BRUNO; EDUARDO TENCA; RAMÓN LEIGUARDA
Irritability, psychomotor agitation and progressive insomnia induced by bilateral stimulation of the area surrounding the dorsal subthalamic nucleus (zona incerta) in Parkinson's disease patients.
JOURNAL OF NEUROLOGY; Año: 2009 vol. 256 p. 2091 - 2093
SUSANA ESTEVEZ; SANTIAGO PEREZ-LLORET; MARCELO MERELLO
Does clinical intolerance to a diagnostic acute levodopa challenge differentiate multiple system atrophy from PD?
THE INTERNATIONAL JOURNAL OF NEUROSCIENCE.; Año: 2009 vol. 119 p. 2257 - 2261
DANIEL PEREZ-CHADA; CHRISTOPHER L. DRAKE; SANTIAGO PEREZ-LLORET; ALEJANDRO J. VIDELA; DANIEL CARDINALI
Brief review: diurnal rhythms, obesity and educational achievement in South american cultures.
THE INTERNATIONAL JOURNAL OF NEUROSCIENCE.; Año: 2009 vol. 119 p. 1091 - 1104
SANTIAGO PEREZ-LLORET; MARIELA AMAYA; MARCELO MERELLO
Pregabalin-induced parkinsonism: a case report.
CLINICAL NEUROPHARMACOLOGY; Año: 2009 vol. 32 p. 353 - 354
JOSÉ BONET; BRANCO MAUTNER; SORAYA KERBAGE; MARÍA FERNANDA BONET; SANTIAGO PEREZ LLORET
Vital exhaustion is significantly linked to acute coronary events in Argentine population.
Vertex; Año: 2009 vol. 20 p. 421 - 426
SANTAIGO PEREZ-LLORET
Rotigotine for the Treatment of Advanced Parkinson’s Disease
European neurological review; Año: 2009 vol. 4 p. 24 - 28
OLIVIER RASCOL; SANTIAGO PEREZ LLORET
Rotigotine transdermal delivery for the treatment of Parkinson's disease.
EXPERT OPINION ON PHARMACOTHERAPY; Año: 2009 vol. 10 p. 677 - 691
SANTIAGO PEREZ-LLORET; MARCELO RISK; DIEGO A. GOLOMBEK; DANIEL P. CARDINALI; RAMIRO SANCHEZ; AGUSTÍN RAMIREZ
Blunting of circadian rhythms and increased acrophase variability in asleep hypertensive subjects
Chronobiology Internacional; Año: 2008 vol. 25 p. 99 - 113
SANTIAGO PEREZ LLORET; MALCO ROSSI; DANIEL P. CARDINALI; MARCELO MERELLO
Validation of the sleep related items of the Non-motor Symptoms Questionnaire for Parkinson’s disease (NMSQuest)
PARKINSONISM & RELATED DISORDERS; Año: 2008 vol. 14 p. 641 - 645
MARCELO MERELLO; EDUARDO TENCA; SANTIAGO PEREZ-LLORET; MARÍA EUGENIA MARTN; VERÓNICA BRUNO; SOL CAVANAGH; JULIO ANTICO; RAMÓN LEIGUARDA; SANTIAGO PEREZ LLORET
Prospective randomized one year follow up comparison of bilateral subthalamotomy versus bilateral subthalamic stimulation and the combination of both in Parkinson’s disease patients: A pilot study
British Journal of Neurosurgery; Año: 2008 vol. 22 p. 415 - 421
SANTIAGO PEREZ LLORET; JORGE TOBLLI; DANIEL CARDINALI; JUAN CLAUDIO MALATESTE; JOSÉ MILEI
Nocturnal hypertension defined by fixed cut-off limits is a better predictor of left ventricular hypertrophy than non-dipping
INTERNATIONAL JOURNAL OF CARDIOLOGY; Año: 2008 vol. 127 p. 387 - 389
SANTIAGO PEREZ LLORET; GABRIEL PIRÁN ARCE; MALCO ROSSI; MARÍA LAURA CAIVANO NEMET; PAZ SALSAMENDI; MARCELO MERELLO
Validation of a new scale for the evaluation of sialorrhea in Patients with Parkinson’s Disease
MOVEMENT DISORDERS; Año: 2007 vol. 22 p. 107 - 111
DANIEL PEREZ-CHADA; SANTIAGO PEREZ LLORET; ALEJANDRO J. VIDELA; DANIEL CARDINALI; MIGUEL A. BERGNA; MARIANO FERNÁNDEZACQUIER; LUIS LARRATEGUY; GUSTAVO E. ZABERT; CHRISTOPHER DRAKE
Sleep disordered breathing and daytime sleepiness are associated with poor academic performance in teenagers. A study using the pediatric daytime sleepiness scale (PDSS)
SLEEP.; Año: 2007 vol. 30 p. 1698 - 1703
MARCELO MERELLO; SANTIAGO PEREZ LLORET; JULIO ANTICO; JOSÉ A. OBESO
Dyskinesias induced by Subthalamotomy in Parkinson’s disease are unresponsive to Amantadine
JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY; Año: 2006 vol. 77 p. 172 - 174
HUGO BOQUETE; GABRIEL FIDELEFF; LILIANA ALBORNOZ; SANTIAGO PEREZ LLORET; MARTHA SUAREZ; ANA I. ESQUIFINO; MARGARITA HONFI; DANIEL P. CARDINALI
Gender-related differences in urinary 6-sulfatoxymelatonin levels in obese pubertal individuals.
JOURNAL OF PINEAL RESEARCH; Año: 2006 vol. 40 p. 214 - 218
SANTIAGO PEREZ-LLORET; JORGE E. TOBLLI; DANIEL E. VIGO; DANIEL P. CARDINALI; JOSÉ MILEI
Infradian awake and asleep systolic and diastolic blood pressure rhythms in humans
JOURNAL OF HYPERTENSION; Año: 2006 vol. 24 p. 1273 - 1279
SANTIAGO PEREZ-LLORET
Tratamiento Quirúrgico de la Enfermedad de Parkinson.
REVISTA NEUROLOGICA ARGENTINA (ED. IMPRESA); Año: 2006 vol. 31 p. 123 - 128
VERÓNICA BRUNO; PABLO SCACCHI; SANTIAGO PEREZ LLORET; ANA ESQUIFINO; DANIEL CARDINALI; RODOLFO CUTRERA
Melatonin treatment counteracts the hyperthermyc effect of Lipopolysaccharide injection in the Syrian Hamster
NEUROSCIENCE LETTERS; Año: 2005 vol. 389 p. 169 - 172
SANTIAGO PEREZ LLORET; ALEJANDRO GARCÍA AGUIRRE; DANIEL P. CARDINALI; JORGE E. TOBLLI
Disruption of ultradian and circadian rhythms of blood pressure in nondipper hypertensive patients
HYPERTENSION; Año: 2004 vol. 44 p. 311 - 315
BOGGIO VI; CASTRILLÓN PO; RICCIO P; PEREZ LLORET S; ESQUIFINO AI; CARDINALI DP; CUTRERA RA
Cerebroventriular Administration of Interferon-gamma modifies locomotor activity in the Golden Hamster
Neurosignals; Año: 2003 vol. 12 p. 89 - 94
MARGARITA BLANCO; NORBERTO KRIGUER; SANTIAGO PÉREZ LLORET; DANIEL P. CARDINALI
Attitudes towards treatment among patients suffering from sleep disorders. A Latin American survey
BMC Family Practice; Año: 2003 vol. 4 p. 17 - 23
LUIS GIROTTI; MANUEL LAGO; OSCAR IANOVSKY; MARCELO V. ELIZARI; ANDRÉS DINI; SANTIAGO PÉREZ LLORET; LILIANA E. ALBORNOZ; DANIEL P. CARDINALI
Low urinary 6-Sulphatoximelatonin levels in patients with severe congestive heart failure
ENDOCRINE; Año: 2003 vol. 22 p. 245 - 248
FURIO AM; CUTRERA RA; CASTILLO THEA V; PÉREZ LLORET S; RICCIO P; CACCURI RL; BRUSCO LI; CARDINALI DP
Effect of Melatonin on Changes in Locomotor Activity Rhythm of Syrian Hamsters Injected With Beta Amyloid Peptide 25–35 in the Suprachiasmatic Nuclei
CELLULAR AND MOLECULAR NEUROBIOLOGY.; Año: 2002 vol. 22 p. 699 - 709
CARDINALI DP; BORTMAN GP; LIOTTA G; PÉREZ LLORET S; ALBORNOZ LE; CUTRERA RA; BATISTA J; ORTEGA GALLO P
A Multifactorial Approach Employing Melatonin to Accelerate Resynchronization of Sleep-Wake Cycle After a 12 Time-Zone Transmeridian Flight in Elite Soccer Athletes
JOURNAL OF PINEAL RESEARCH; Año: 2002 vol. 32 p. 41 - 46
CARDINALI DP; BRUSCO LI; PÉREZ LLORET S; FURIO A
Melatonin in Sleep Disorders and Jet-lag
Neuroendocrinology Letters; Año: 2002 vol. 23 p. 9 - 13
CARDINALI DP; GVOZDENOVICH E; KAPLAN MR; FAINSTEIN I; SHIFIS HA; PÉREZ LLORET S; ALBORNOZ L; NEGRI A
A double blind placebo controlled study on melatonin efficacy to reduce anxiolityc benzodiazepine use in the elderly
Neuroendocrinology Letters; Año: 2002 vol. 23 p. 55 - 61